Artículo original
Vol. 1 | Num. 1 (Eng.)
30 min
Cómo citar
Métricas
71
Visualizaciones
3
Descargas
Compartir
Compartir
Resumen (EN)
Palabras clave (EN):
Diabetes is a chronic disease caused by inappropriate regulation of blood glucose levels. Normally, insulin regulates blood glucose levels, but in individuals with type 1 diabetes, this hormone is not produced. Type 2 diabetes is characterized by resistance and reduced insulin secretion.(1)
Diabetic foot is one of the most common complications of diabetes caused by hyperglycemia, which injures the peripheral blood vessels and nerves, resulting in dry and irritated skin on the foot and eventually forming ulcers that do not heal for a prolonged time, which decreases the patients' quality of life. Patients with diabetic foot experience a significant impact on their quality of life, particularly regarding physical and emotional functionality. Approximately 15% of people with diabetes will have foot ulcers at some point in their lives. A foot ulcer is a wound that extends through the full thickness of the skin below the level of the ankle. (2) It is considered one of the most common and devastating chronic complications of diabetes because it contributes to high morbidity, high hospitalization rates, and high mortality, all of which threaten the patient's quality of life. The risk of developing a diabetic foot ulcer in a patient over their lifetime is between 12-25%, with a recurrence rate of 50-70% over 5 years. Following an amputation of a lower limb, the risk of losing the other limb within 3 years is 50%. (3) Various classification systems can be used to define the severity of the ulcer in patients with diabetic foot. The Wagner scale was one of the first classifications described and has historically been the most used, although its use is rare today. New classifications have emerged, such as PEDIS, the University of Texas wound classification, SINBAD, and WIFi. Failure to heal ulcers can lead to amputation; individuals with diabetes have a 10 to 20 times greater risk of losing a lower limb or part of a lower limb due to non-traumatic amputation than individuals without diabetes. (2)
Currently, one of the most commonly used scales is the Texas University scale, which is divided into grades from 0-III and stages A-D; the risk of amputation varies depending on the stage in which it is located. (4)
Wound healing consists of 4 phases: hemostasis, inflammation, proliferation, and maturation. In patients with chronic wounds, such as diabetic foot ulcers, these 4 phases are disrupted, leading to the chronicity of the ulcers. In the case of diabetic foot ulcers, the inflammation phase is prolonged due to a hypoxic environment. Approximately 12% of patients with diabetes undergo amputation, either major or minor, each year in England due to ulcers, and only half of them survive 2 years post-amputation. (5) Diabetic foot is the most common cause of non-traumatic amputations, accounting for up to 85%. (6)
Negative pressure therapy is a technology that is widely used in the treatment of wounds. (1) It is a biophysical agent consisting of a mechanical unit attached to a dressing through a plastic tube, which connects to a suction device, allowing the creation of a sub-atmospheric pressure at the wound site. (5) It includes an open-cell polymer foam dressing. (7) It removes the fluids secreted by the wound through negative suction. (8) It aids in the treatment of wounds by collecting large volumes of wound exudate, reducing the frequency of dressing changes by keeping anatomically challenging wounds such as those on the foot clean and reducing odor. It is also said that the application of mechanical force to the wound provides biologically plausible processes by which wound healing is promoted. (1)
Negative pressure therapy is a method for wound management believed to facilitate healing through changes in growth factor expression, micro and macro deformation, blood flow, exudate removal, and bacterial concentration in the wound. The mechanisms by which negative pressure therapy promotes wound healing are still not well understood. It has been shown to increase tissue perfusion due to enhanced angiogenesis secondary to a hypoxic environment, increases growth factors, decreases wound exudate, which leads to reduced pressure in the tissue, allowing for greater perfusion and creating a more favorable environment for healing. The most common indications for the use of negative pressure therapy are open traumatic acute wounds, diabetic and neuropathic ulcers, debrided postoperative open wounds, high-risk surgical incisions, and tissue grafts and flaps. (9) It has been shown to produce a greater reduction in wound size compared to conventional dressings. (10) It has certain adverse effects such as wound maceration, infection, bleeding, and dressing retention. (11)
Peripheral arterial disease affects 12-20% of Americans over the age of 60, increasing to 50% after the age of 85. The prevalence increases with age. (12) The main risk factors are smoking, diabetes, hypertension, dyslipidemia, chronic kidney disease, age, male gender, sedentary lifestyle, and obesity. (13) Peripheral arterial disease and diabetes are related in patients at risk of amputation. Having peripheral arterial disease increases the risk of amputation by four times in patients with diabetes. (14) In patients who already have pain or gangrene in the foot, there is a 22% mortality rate per year and a risk of amputation of the limb within a year. (15)
The concept of using controlled subatmospheric pressure to treat open or infected wounds was initially described by Fleischmann et al in 1993. (16) The first documented use of negative pressure therapy was in 1997 by Argenta et al, for refractory acute and chronic wounds or those with a poor response to conventional treatment. A study was conducted on 175 chronic wounds, which included pressure ulcers and non-healing wounds; 94 subacute wounds, which included infection or dehiscence of surgical sites, tissue avulsion, and open amputations less than one week old; and 31 acute wounds, which included acute avulsions or eviscerations, hematomas, gunshot wounds, and open wounds less than one day old. Chronic wounds healed in 166 patients, 6 patients passed away during treatment, and 3 patients experienced recurrence of their pressure ulcer due to inadequate compliance with treatment. All subacute wounds healed, 28 with pure negative pressure therapy and 68 with negative pressure therapy followed by a graft, flap, or second intention closure. One patient died with an acute wound during management, while the other 30 wounds closed successfully. The authors believe that of the 296 wounds, granulation tissue formed more quickly with negative pressure therapy compared to if it had not been used. This comparison was subjective. (17)
Clare et al conducted a retrospective review in diabetic patients with non-healing lower limb, foot, and ankle wounds. The average duration of treatment was 8.2 weeks, and 82% of the wounds healed successfully. The 3 patients who did not heal had severe peripheral arterial disease. (18)
Akbari et al reported a randomized controlled trial evaluating negative pressure therapy in diabetic foot ulcers in 18 patients. They received debridement, antibiotics, blood glucose management, and daily dressing changes. The experimental group received negative pressure therapy as their wound dressing. This group had a significantly greater reduction in the average surface area of the ulcers compared to the controls. (19)
Zhang et al conducted a meta-analysis including 8 studies with 669 patients to determine the efficacy and safety of negative pressure therapy in patients with diabetic foot ulcers compared to patients who did not receive it. A significant reduction in major amputations was observed, but no significant difference in minor amputations was noted. (20)
If Liu et al conducted a meta-analysis evaluating negative pressure therapy in patients with diabetic foot ulcers, demonstrating that negative pressure therapy reduces wound healing time compared to standard treatment with dressings, it similarly showed that the incidence of amputation is lower in patients treated with this therapy. (3)
Matthew Wynn conducted a systematic review on the efficacy of negative pressure therapy in patients with diabetic foot ulcers, where three studies showed a significant reduction in amputations in patients treated with this therapy; however, none of the studies provided an explanation for the lower incidence. (5)
In a systematic review of the Cochrane database on negative pressure therapy in patients with diabetic foot ulcers, where articles comparing this therapy vs dressings were analyzed, they found 3 articles that reported that negative pressure therapy may decrease the risk of amputation; however, they do not specify whether it is major or minor amputation. In conclusion, it was observed that there is very little and low-quality evidence suggesting that negative pressure therapy can reduce the risk of amputation. (1)
A retrospective, descriptive, cross-sectional, and single-center study was conducted in patients diagnosed with diabetic foot, in which negative pressure therapy was used, during the period from March 1, 2021, to March 1, 2023, at the General Hospital of Zone #20, Puebla, Puebla. The protocol was approved by the Local Research Committee on Health No. 2108 of the hospital, with registration number R-2023-2108-075. Gender, age, duration of negative pressure system use, and time between each sponge change were analyzed. The surgical technique described in the procedures involved debridement and washing with iodopovidone, followed by irrigation with sterile solution, and then placement of the polyurethane sponge with the negative pressure system. The V.A.C.® Ulta therapy unit from 3M™ Mexico was used.
Information from 50 patients was analyzed. The minimum age was 51 years, the average age was 62, and the maximum age was 80. The most frequent age group was from 60 to 69 years, accounting for 55.4%, followed by the 50 to 59 years group with 33.3%. (Table 1)
Patients with a diagnosis of diabetic ulcer classified as Texas grade IIB, IIC, and IID were included. A total of 20 patients were found with Texas grade IIB, 13 with Texas grade IIC, and 17 with grade IID. (Figure 1)
Negative pressure therapy was used in 50 patients. Amputations of the affected area were performed in 5 patients (10%), while the other 45 patients (90%) showed adequate wound progression without the need for any radical treatment. The 5 mentioned patients are classified as Texas IID.
In the analysis of comorbidities, it was found that 32 (64%) patients had no comorbidities excluding diabetes, while 18 (36%) patients had one or more comorbidities excluding diabetes.
The findings presented in this study are of utmost importance and relevance as there are no prior data at the General Hospital of Zone 20, IMSS Puebla, regarding patients with diabetic foot ulcers treated with negative pressure therapy.
The mean age of the patients in the study was 62 years, with a range from 51 to 80 years. This suggests that the studied population is older, which is consistent with the trend that diabetic foot ulcers more frequently affect older individuals. Most of the patients were in the age group of 60 to 69 years (64%), followed by the group of 50 to 59 years (12%). This information is relevant for understanding the at-risk population and may help direct specific prevention and treatment strategies for these age groups. Patients with grade II ulcers according to the Texas classification were studied because these patients have a higher likelihood of limb salvage compared to those with grade III, who have bone involvement and in most cases this indicates amputation.
Most patients (64%) had no comorbidities other than diabetes, while 36% had one or more comorbidities. This suggests that the presence of other comorbidities could increase the risk of complications in patients with diabetic foot ulcers. Negative pressure therapy was used for a variable period, with a minimum of 5 days and a maximum of 15 days. This may be relevant for assessing the optimal duration of this treatment and its effectiveness in different clinical contexts.
Maranna et al investigated the efficacy of negative pressure wound therapy (NPWT) compared to saline dressings for diabetic foot ulcers of grades 1 and 2 of the Wagner classification. Conducted in 45 patients, the study demonstrates that the group treated with NPWT (22 patients) had significantly greater granulation tissue formation and a reduction in ulcer size compared to the saline dressing group (23 patients) after 14 days. A shorter hospital stay and a shorter time to complete wound healing were also observed in the NPWT group. After 3 months, 90.9% of patients treated with NPWT had completely healed, in contrast to only 26.1% of the saline dressing group. (21)
In our study, it was observed that out of 45 patients, none required radical amputation, as adequate debridement, washing, and subsequent application of negative pressure system led to favorable outcomes. In the other 5 patients, radical amputation was necessary because they did not progress adequately, which was evaluated by tissue granulation formation and infection progression. It is important to note that these were Texas IID ulcers, which means they already presented infection and vascular compromise. This leads us to understand that the risk of amputation in this type of patient is higher than if they only present ischemia or infection separately. Our study showed a decrease in the percentage of amputation in Texas II diabetic foot patients treated with the negative pressure system, comparing the amputation percentage with the original study that validated the Texas classification for diabetic foot ulcers, which presents an amputation prevalence of 28.6% for IIB, 25% for IIC, and 100% for IID. (4)
Negative pressure therapy has been extensively studied in recent years. Diabetic foot ulcers continue to pose a challenge for surgeons when treating them, with the goal of preventing disease progression and avoiding radical treatments. In our study, a decrease in the amputation rate was observed compared to conventional treatments such as simple cleansing and debridement. However, further studies are required to confirm its effectiveness in preventing amputations in diabetic foot ulcers.
| Table 1. Gender and age of the patients. | ||||||||
|---|---|---|---|---|---|---|---|---|
| Female | Male | Total | ||||||
| N | % | n | % | n | % | |||
| Age groups* | 50 to 59 years | 2 | 12.5 | 4 | 11.7 | 6 | 12 | |
| 60 to 69 years | 10 | 62.5 | 22 | 64.7 | 32 | 64 | ||
| 70 to 80 years | 4 | 25 | 8 | 23.5 | 12 | 24 | ||
| Total | 16 | 32 | 34 | 68 | 50 | 100.0 | ||
| n: count, %: percentage. ** Minimum=51, maximum=80, mean=62, standard deviation 5.7.* | ||||||||
Explorar
Artículos
Volúmenes
Sobre la revista
Más leídos
Revista Internacional de Reparación Tisular y Heridas
Revista Internacional de Reparación Tisular y Heridas
Revista Internacional de Reparación Tisular y Heridas
Revista Internacional de Reparación Tisular y Heridas
Revista Internacional de Reparación Tisular y Heridas